Merck Closes Mirus Bio Acquisition, Bolstering Viral Vector Bioprocessing Offering

Advances Merck’s ambition to provide fully integrated and comprehensive solution for viral vector manufacturing

06-Aug-2024 - Merck announced the closing of the transaction to acquire Mirus Bio for approximately US$600million (around €550million), following regulatory clearances and the fulfillment of other customary closing conditions. The acquisition is a strategic step towards Merck's ambition to offer solutions ...

Sartorius opens new Center of Excellence for bioanalytics in Ann Arbor

Manufacturing of instruments, consumables and reagents for cell and protein analysis

07-Jun-2024 - The life science group Sartorius opened its new Center of Excellence for bioanalytics in Ann Arbor, Michigan, two years after breaking ground in the Tech Loop at Research Park. Sartorius has invested around 100 million US dollars in the state-of-the-art facility, consolidating existing sites and ...

Merck Signs Definitive Agreement to Acquire Life Science Company Mirus Bio for US$ 600 million

"This strategic acquisition is a further building block for accelerating growth in the break-through technologies of the future"

24-May-2024 - Merck has signed a definitive agreement to acquire life science company Mirus Bio for US$600million (around €550million). Based in Madison, Wisconsin, USA, Mirus Bio is a specialist in the development and commercialization of transfection reagents. Transfection reagents, such as Mirus Bio's ...

Bio-Techne announces new distribution agreement with Thermo Fisher Scientific

07-May-2024 - Bio-Techne Corporation to announce a significant milestone in its commitment to providing cutting-edge solutions to its customers. Effective May 1, 2024, Bio-Techne will enter into a strategic distribution agreement with Thermo Fisher Scientific in Europe. This partnership marks an important ...

baseclick enters the US market

23-Jan-2024 - baseclick products are now available to customers in the US and around the world via the Labscoop marketplace. Through this agreement, baseclick will offer laboratories and researchers its comprehensive portfolio of high-quality click chemistry reagents and various kit systems for EdU-based cell ...

SUANFARMA announces a collaboration with Reyoung Pharmaceutical

The main objective of the collaboration is to introduce generic pharmaceutical ingredients to the market for the treatment of infectious diseases

19-Oct-2023 - SUANFARMA, through its R&D division, celebrates the historic agreement reached with Reyoung Pharmaceutical, a leader in the manufacture of active ingredients since 1966. Reyoung´s decades of experience as an exporter of products worldwide are perfectly aligned with SUANFARMA, which has been ...

Danaher to Acquire Abcam

30-Aug-2023 - Danaher Corporation announced that it has entered into a definitive agreement to acquire Abcam plc, a leading global supplier of protein consumables, pursuant to which Danaher will acquire all of the outstanding shares of Abcam for $24.00 per share in cash, or a total enterprise value of ...

Merck Invests Approximately € 70 Million to Expand Reagent Manufacturing in China

Major investment at company’s Nantong site reflects Merck’s China strategy

30-Jun-2023 - Merck is expanding production capacity for highly-purified reagents at its site in Nantong, China, a major transportation hub in the Yangtze River Delta region. The approximate €70million investment will allow the large-scale manufacturing of high-purity reagents for quality control and testing ...

Sartorius acquires French provider of innovative upstream technologies for cell and gene therapies

Agreed purchase price of approximately 2.4 billion euros

03-Apr-2023 - The life science group Sartorius, through its French listed subgroup Sartorius Stedim Biotech, has signed an agreement to acquire Polyplus for approximately 2.4 billion euros from private investors including ARCHIMED and WP GG Holdings IV B.V., an affiliate of Warburg Pincus. Polyplus, with ...

ChromaTwist lands second round of equity funding to develop fluorescent dyes for the flow cytometry market

22-Nov-2022 - University of Birmingham spinoutChromaTwist Ltd has secured £487k of equity investment to develop its new class of fluorescent dyes for the flow cytometry reagent market. This second round of equity investment, which brought in funds from Directors, existing Angel investors, angelgroups and the ...